-
Mashup Score: 3
Reducing the levels of triglycerides and triglyceride-rich lipoproteins remains an unmet clinical need. Olezarsen is an antisense oligonucleotide targeting messenger RNA for apolipoprotein C-III (A…
Source: www.nejm.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 2
Reducing the levels of triglycerides and triglyceride-rich lipoproteins remains an unmet clinical need. Olezarsen is an antisense oligonucleotide targeting messenger RNA for apolipoprotein C-III (A…
Source: www.nejm.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0
In patients with an acute coronary syndrome who had percutaneous coronary intervention with contemporary drug-eluting stents and remained event-free for 1 month on dual antiplatelet therapy, treatment with ticagrelor alone between month 1 and month 12 after the intervention resulted in a lower rate of clinically relevant bleeding and a similar rate of MACCE compared with ticagrelor plus aspirin. Along with the results from previous studies, these findings show that most patients in this population can benefit from superior clinical outcomes with aspirin discontinuation and maintenance on ticagrelor monotherapy after 1 month of dual antiplatelet therapy.
Source: www.thelancet.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 2
Reducing the levels of triglycerides and triglyceride-rich lipoproteins remains an unmet clinical need. Olezarsen is an antisense oligonucleotide targeting messenger RNA for apolipoprotein C-III (A…
Source: www.nejm.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0Microsoft Virtual Events Powered by Teams - 5 month(s) ago
Microsoft Virtual Events Powered by Teams
Source: events.teams.microsoft.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0The Dad Canon (Circa Now) - 11 month(s) ago
Our highly specific, clearly subjective taxonomy of what today’s dads can’t stop wearing, reading, and talking about.
Source: www.nytimes.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1Atrial Pacing for Chronotropic Incompetence in HFpEF - 1 year(s) ago
This randomized crossover trial assessed if implanting and programming a pacemaker for rate-adaptive atrial pacing improved exercise performance in patients with heart failure with preserved ejection fraction and chronotropic incompetence at a single US tertiary referral center.
Source: jamanetwork.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0
Susan Smyth, MD, PhD, FACC, former ACC Kentucky Chapter Governor and a member of the ACC’s Academic Cardiology Section Leadership Council, passed away on Dec. 31, 2022, following a battle with cancer. Smyth was executive vice chancellor and dean of the College of Medicine at the University of Arkansas for Medical Sciences (UAMS). An accomplished cardiologist and translational scientist, Smyth…
Source: American College of CardiologyCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1Heart Tank for the Cardiovascular Investigator: Congenital Heart - American College of Cardiology - 1 year(s) ago
December 6, 2022 7:00 PM iCal Meeting Type: Webinars – Live Location: Online – Eastern Time (ET) The goal of this webinar is to help academic cardiologists conduct successful research and gain the tools they need…
Source: American College of CardiologyCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Heart Tank For the Cardiovascular Investigator: Electrophysiology - American College of Cardiology - 2 year(s) ago
September 15, 2022 7:00 PM iCal Meeting Type: Webinars – Live Location: Online – Eastern Time (ET) The goal of this webinar is to help academic cardiologists conduct successful research and gain the tools they need…
Source: American College of CardiologyCategories: Cardiologists, Latest HeadlinesTweet
Presented at #ACC24 just now: Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk | New England Journal of Medicine https://t.co/bvii81DbdV